Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 9, 2018
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
[ Fri, Feb 09th 2018
] - WOPRAI
Thu, February 8, 2018
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
[ Thu, Feb 08th 2018
] - WOPRAI
Douglas Miehm Initiated (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018
Douglas Miehm of RBC Capital, Initiated "Aurinia Pharmaceuticals Inc." (AUPH) at Buy and Held Target at $9 on, Feb 8th, 2018.
Douglas has made no other calls on AUPH in the last 4 months.
There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Douglas
- Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $14 on, Monday, October 23rd, 2017
Similar Stocks and Investing Articles
[ Fri, Jan 19th 2018
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Mon, Oct 23rd 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Mon, Nov 09th 2015
] - WOPRAI
[ Mon, Apr 21st 2014
] - WOPRAI
[ Thu, Oct 31st 2013
] - WOPRAI